INTERVIEWS

Dr. Zoe Memel, MD, PG1, Department of Medicine, Massachusetts General Hospital discusses the research presented at Digestive Disease Week® (DDW) 2020 titled “Aspirin use is associated with a reduced incidence of hepatocellular carcinoma: a systematic review and meta-analysis”

Dr. Eric A. Klein, Chairman of the Glickman Urological & Kidney Institute and a staff member in the Taussig Cancer Institute at Cleveland Clinic, discusses prostate cancer research released at the American Urological Association (AUA) 2020 meeting demonstrating the positive impact of the Oncotype DX Genomic Prostate Score® (GPS™) test to help make treatment decisions in African-American men with clinically localized prostate cancer.  He was also author on the abstract titled “A 17-Gene Genomic Assay as a Predictor of Outcomes in African Americans with Prostate Cancer” presented at AUA. 

Dr. Robert Giugliano, MD, discusses data released from the FOURIER study, an analysis evaluating patient-reported cognition in high-risk heart disease patients, including patients achieving low levels of LDL-cholesterol after an average of two years of treatment.  The data were published in the “Journal of the American College of Cardiology” May 2020 

Jodi Parker, a cancer advocate and patient living with advanced lung cancer shares her journey and her involvement with Merck’s and the GO2 Foundation for Lung Cancer’s new patient awareness initiative “Worth the Fight: Taking on Lung Cancer” that offers support and resources to people impacted by advanced lung cancer and empowers them to take an active role in their cancer care.

Dr. Marcia Brose, Associate Professor at the University of Pennsylvania School of Medicine discusses the role of cancer genomic testing and Neurotrophic Tropomyosin Receptor Kinase (NTRK) gene fusions.  NTRK gene fusions can cause cancer cells to multiply, form tumors, and are more common in certain thyroid and colon cancer subtypes.  Bayer and Neogenomics Inc. launched the Test4TRK™ program to offer genomic cancer testing for NTRK gene fusions at no cost for patients who meet certain criteria. 

Dr. Sean Boynes, DMD, MS, Vice President of Health Improvement at DentaQuest discusses teledentistry an unexpected outcome of the COVID-19 pandemic. 

Eleusis is a clinical-stage life science company that has two lines of business:  a traditional drug development arm called Eleusis Therapeutics, and a care delivery platform called Eleusis Health Solutions.  Here to discuss the company and the potential and power of psychedelic medicine in treating chronic inflammatory disease, mental health, and Alzheimer’s is CEO, founder, and chairman, Shlomi Raz.

Founder and CEO of Miiskin Jon Friis discusses the partnership between the Skin Cancer Foundation and Miiskin for Skin Cancer Awareness Month to remind people to perform self-skin exams.  Miiskin is a digital health platform supported by the dermatological community as a tool to help track skin changes.

Bonnie J. Addario, Co-Founder, Board Chair, GO2 Foundation for Lung Cancer discusses the foundation along with other patient advocacy group’s support of Guardant Health’s “Clear Your View” campaign to bring awareness around comprehensive genomic testing for patients with metastatic non-small cell lung cancer (NSCLC) before first-line treatment.

Dr. Benjamin Levy, Division Head Of Gastroenterology at Mount Sinai Hospital in Chicago, discusses the impact the pandemic has had on colorectal cancer screening and diagnostics, the expected backlog when offices open back up, and the role at-home tests (like Cologuard®) can play to filter the right people into diagnostic screening.